RTN2 and gastric cancer: Transwell assays demonstrated that both gastric cancer cells exhibited a higher migratory and invasive potential when RTN2 was overexpressed (Fig. 3C, D), while the migratory and invasive abilities were impaired when RTN2 was knocked down (Fig. 3E, F).